Cite

    Naya, N. et al. (2021). Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study. Neuropsychopharmacology reports. 41 (1), pp. 26-39. [Online].